期刊文献+

增生型糖尿病视网膜病变患者血浆和玻璃体中VEGF和低密度脂蛋白受体相关蛋白6的表达及其相关性 被引量:12

Expression and correlation of LRP6 and VEGF in plasma and vitreous of PDR patients
下载PDF
导出
摘要 目的通过定量检测血管内皮生长因子(vascular endothelial growth factor,VEGF)和低密度脂蛋白受体相关蛋白6(low density lipoprotein receptor-related protein 6,LRP6)在增生型糖尿病视网膜病变(proliferative diabetic retinopathy,PDR)患者血浆和玻璃体中的表达水平,并探究其相关关系,为PDR的防治提供依据。方法选择PDR患者60例,非增生型糖尿病视网膜病变(non proliferative diabetic retinopathy,NPDR)患者62例,单纯性糖尿病患者(对照组)55例。ELISA检测各组血浆和玻璃体中VEGF、LRP6浓度,并对三组检测指标进行统计学比较。结果 PDR组血浆和玻璃体VEGF浓度显著高于对照组和NPDR组,差异均有统计学意义(均为P<0.05)。对照组和NPDR组差异具有统计学意义(P<0.05)。PDR组玻璃体中LRP6浓度高于NPDR组和对照组,差异均具有统计学意义(均为P<0.05)。NPDR组和对照组玻璃体中LRP6差异具有统计学意义(P<0.05)。各组血浆中LRP6浓度差异无统计学意义(P>0.05)。PDR组血浆和玻璃体中VEGF浓度呈显著正相关(r=0.60,P<0.05)。结论 PDR患者血浆和玻璃体中VEGF与LRP6水平能较好反映视网膜新生血管活动情况,检测血浆和玻璃体中VEGF与LRP6水平可为早期诊断PDR提供理论依据。 Objective To analyze the expression level of vascular endothelial growth factor(VEGF) and lowdensity lipoprotein receptor-related protein 6(LRP6) in plasma and vitreous of patients with proliferative diabetic retinopathy(PDR),explore the relationship between LRP6 and VEGF,and provide evidence for the prevention and treatment of PDR. Methods Sixty cases of patients with PDR and 62 cases of patients with NPDR were selected,and 55 patients with simple diabetes were studied as control group. The concentrations of LRP6 and VEGF in plasma and vitreous were detected by ELISA,and the three groups were statistically compared. Results The concentrations of VEGF in PDR group were significantly higher than those in control group and NPDR group,and the differences were statistically significant(all P 〈 0. 05),and the difference between the control group and the NPDR group was also statistically significant(P 0. 05). The concentrations of LRP6 in PDR group were significantly higher than those in NPDR group and control group,the differences were statistically significant(all P 〈 0. 05),and the difference between the control group and the NPDR group was also statistically significant(P 〈 0.05). There was no significant difference in plasma LRP6 concentrations(P 〉0. 05). The levels of VEGF in plasma and vitreous in PDR group were significantly positively correlated(r = 0. 60,P 〈0. 05). Conclusion The level of LRP6 and VEGF in plasma and vitreous of patients with PDR can reflect the activity of retinal neovascularization,and the level of LRP6 and VEGF in the plasma and vitreous can provide a theoretical basis for early diagnosis of PDR.
出处 《眼科新进展》 CAS 北大核心 2016年第3期278-280,共3页 Recent Advances in Ophthalmology
关键词 增生型糖尿病视网膜病变 血管内皮生长因子 低密度脂蛋白受体相关蛋白6 proliferative diabetic retinopathy vascular endothelial growth factor low-density lipoprotein receptor-related protein 6
  • 相关文献

参考文献5

二级参考文献99

  • 1李才锐,孙曙光,姜德咏,洪卫.银杏叶提取物治疗早期糖尿病视网膜病变观察[J].国际眼科杂志,2006,6(1):78-81. 被引量:36
  • 2王鲁伃,刘素筠.血栓调节蛋白及纤溶酶原激活物抑制剂-1在糖尿病视网膜病变中的作用[J].医学综述,2006,12(10):593-595. 被引量:5
  • 3王少波,施秉银,王养维,吴贵福.糖尿病视网膜病变时t-PA和PAI-1活性变化的临床意义[J].国际医药卫生导报,2006,12(8):46-47. 被引量:3
  • 4Finis D, Stammen J, Joussen AM. Familial exudative vitreoretinopathy. Ophthalmologe, 2010,107 : 683-693.
  • 5Nikopoulos K, Venselaar H, Collin RW, et al. Overview of the mutation spectrum in familial exudative vitreoretinopathy and Norrie disease with identification of 21 novel variants in FZD4, LRP5, and NDP. Hum Mutat,2010,31:656-666.
  • 6Hiraoka M, Takahashi H, Orimo H, et ah Genetic screening of Wnt signaling factors in advanced retinopathy of prematurity. Mol Vis, 2010,16 : 2572-2577.
  • 7Robitaille JM, Zheng B, Wallace K, et al. The role of Frizzled-4 mutations in familial exudative vitreoretinopathy and Coats disease. Br J Ophthalmol, 2011, 95 : 574-579.
  • 8Ells A, Guernsey DL, Wallace K, et al. Severe retinopathy of prematurity associated with FZD4 mutations. Ophthalmic Genet,2010,31:37-43.
  • 9Drenser KA, Dailey W, Vinekar A, et al. Clinical presentation and genetic correlation of patients with mutations affecting the FZD4 gene. Arch Ophthalmol, 2009,127 : 1649-1654.
  • 10Muller M, Kusserow C, Orth U, et al. Mutations of the frizzled-4 gene. Their impact on medical care of patients with autosomal dominant exudative vitreoretinopathy. Ophthalmologe, 2008,105 : 262-268.

共引文献21

同被引文献134

引证文献12

二级引证文献105

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部